Total planned funding: $128,910,040
Allocations
Countries/Regions
Ukraine | $128,910,040 |
Organizational Types
Private Contractor | $33,564,481 |
Unknown | $28,093,032 |
NGO | $22,278,854 |
Multi-lateral Agency | $15,001,607 |
Own Agency | $14,915,972 |
University | $5,760,000 |
Other USG Agency | $5,224,094 |
Implementing Agency | $4,072,000 |
Program Areas
Governance and Systems | $57,895,047 |
Treatment | $24,505,798 |
Prevention | $14,690,462 |
Testing | $11,508,250 |
Management and Operations | $10,237,791 |
Care | $10,072,692 |
Budget Codes
OHSS: Health Systems Strengthening | $28,414,878 |
HVSI: Strategic Information | $17,540,940 |
HTXS: Treatment: Adult Treatment | $13,100,508 |
HLAB: Laboratory Infrastructure | $11,939,229 |
HVCT: Testing: HIV Testing and Counseling | $11,508,250 |
HTXD: Treatment: ARV Drugs | $11,405,290 |
HVMS: Management and Operations | $10,237,791 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $7,385,928 |
HVTB: Care: TB/HIV | $6,123,242 |
HVOP: Sexual Prevention: Other Sexual Prevention | $4,196,055 |
HMBL: Biomedical Prevention: Blood Safety | $2,660,722 |
HBHC: Care: Adult Care and Support | $2,145,590 |
HKID: Care: Orphans and Vulnerable Children | $1,803,860 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $293,357 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $154,400 |
HMIN: Biomedical Prevention: Injection Safety | $0 |
Top Partner Programs
Not Available:
$28,093,032
Countries/Regions
Chemonics International:
$17,739,470
Countries/Regions
USG Aggregated Agencies:
$14,100,972
Countries/Regions
Deloitte Consulting Limited:
$13,725,011
Countries/Regions